21+ Series B Healthcare Startups — $645M Raised, Scaling Fast

Series B healthcare companies in 2025-2026 are scaling proven clinical solutions across health systems and payer networks. Our dataset tracks 14 Series B healthcare companies that raised a combined $645M at a $30M median. These companies have typically validated their AI-powered products through clinical trials or real-world evidence studies and are now focused on expanding market share. The $30M median — below the overall Series B median of $53M — reflects healthcare's longer validation cycles, but the $645M aggregate shows meaningful capital deployment. Investor focus is on revenue growth, clinical validation metrics, and payor reimbursement pathways. Behavioral health integration, provider credentialing automation, and AI-powered revenue cycle management are seeing particular Series B momentum. For GTM teams, these 14 companies have established procurement processes and dedicated vendor management teams. Enterprise deals in the $100K-$500K range are typical. Target VP of Operations, CTO/CIO, and VP of Strategic Partnerships.